<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00863967</url>
  </required_header>
  <id_info>
    <org_study_id>KSBH: 216/03</org_study_id>
    <nct_id>NCT00863967</nct_id>
  </id_info>
  <brief_title>Early Detection of Arteriosclerosis</brief_title>
  <official_title>Prospective Observational Cohort Study for Early Detection of Arteriosclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Baselland Bruderholz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Baselland Bruderholz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Arteriosclerosis is a common chronic disease with well known risk factors like diabetes
      mellitus, hypertension, dyslipidemia, adipositas and smoking, leading to severe complications
      like myocardial infarction, stroke or peripheral arterial occlusive disease. In addition to
      life-style factors there is also a genetic predisposition to develop complicated
      atherosclerosis.

      Objective: Improve individual risk prediction by clinical phenotyping and genotyping.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      About 300 patients who are treated for various conditions at the department of general
      medicine at our hospital will be included prospectively in the study. This observational
      cohort will be followed for at least 10 years follow-up examinations.

      At baseline and during follow up visits detailed clinical phenotyping is planned (medical and
      family history,standardized clinical and physical examinations, lab, RX, ECG, stress-test or
      echocardiogram). The genotyping is performed by DNA-isolation from leucocytes collected at
      baseline.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>October 2003</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular events</measure>
    <time_frame>10 years at least</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease activity score</measure>
    <time_frame>2 / 5 / 10 years</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">269</enrollment>
  <condition>Arteriosclerosis</condition>
  <condition>Atherosclerosis</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Stroke</condition>
  <condition>Diabetes Mellitus</condition>
  <condition>Peripheral Arterial Occlusive Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>no cardiovascular events</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>proven cardiovascular events</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>possible cardiovascular events</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood / serum / white cells / plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        teaching hospital primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years and older

          -  informed consent

        Exclusion Criteria:

          -  life-threatening disease

          -  life expectancy &lt; 1 month

          -  uncapable to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara Biedermann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Department Kantonsspital Bruderholz CH-4101 Bruderholz</affiliation>
  </overall_official>
  <reference>
    <citation>Biedermann BC, Sahner S, Gregor M, Tsakiris DA, Jeanneret C, Pober JS, Gratwohl A. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet. 2002 Jun 15;359(9323):2078-83.</citation>
    <PMID>12086762</PMID>
  </reference>
  <reference>
    <citation>Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, Witztum JL. Innate and acquired immunity in atherogenesis. Nat Med. 2002 Nov;8(11):1218-26. Review.</citation>
    <PMID>12411948</PMID>
  </reference>
  <reference>
    <citation>Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 2002 Jul 18;347(3):185-92.</citation>
    <PMID>12124407</PMID>
  </reference>
  <reference>
    <citation>Nabel EG. Cardiovascular disease. N Engl J Med. 2003 Jul 3;349(1):60-72. Review. Erratum in: N Engl J Med. 2003 Aug 7;349(6):620.</citation>
    <PMID>12840094</PMID>
  </reference>
  <reference>
    <citation>Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation. 2002 Feb 5;105(5):570-5.</citation>
    <PMID>11827921</PMID>
  </reference>
  <reference>
    <citation>Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999 Jan 14;340(2):115-26. Review.</citation>
    <PMID>9887164</PMID>
  </reference>
  <reference>
    <citation>Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3893-7.</citation>
    <PMID>7732003</PMID>
  </reference>
  <reference>
    <citation>Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP 3rd, Herderick EE, Cornhill JF. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 1999 Feb 24;281(8):727-35.</citation>
    <PMID>10052443</PMID>
  </reference>
  <reference>
    <citation>Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, Sone T, Tanaka M, Yokota M. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med. 2002 Dec 12;347(24):1916-23.</citation>
    <PMID>12477941</PMID>
  </reference>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2009</study_first_submitted>
  <study_first_submitted_qc>March 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2009</study_first_posted>
  <last_update_submitted>March 17, 2009</last_update_submitted>
  <last_update_submitted_qc>March 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 18, 2009</last_update_posted>
  <responsible_party>
    <name_title>Barbara Biedermann MD</name_title>
    <organization>Department of medicine, Kantonsspital Bruderholz, CH-4101 Bruderholz</organization>
  </responsible_party>
  <keyword>physical examination</keyword>
  <keyword>diagnostic techniques and procedures</keyword>
  <keyword>diagnosis</keyword>
  <keyword>immunologic tests</keyword>
  <keyword>diagnostic tests</keyword>
  <keyword>causality</keyword>
  <keyword>genetic test</keyword>
  <keyword>biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

